Getein Biotech, Inc (SHA:603387)

Getein Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	345.46	351.6	484.33	646.25	968.9	801.5
Trading Asset Securities	794.61	648.88	451.91	511.14	612.68	594.92
Cash & Short-Term Investments	1,140	1,000	936.24	1,157	1,582	1,396
Cash Growth	-2.66%	6.86%	-19.11%	-26.82%	13.26%	22.83%
Accounts Receivable	372.3	359.65	453.18	502.1	445.96	458.67
Other Receivables	46.14	50.29	133.31	37.36	37.45	20.81
Receivables	418.43	409.94	586.49	539.45	483.41	479.48
Inventory	177.77	194.46	229.71	269.39	252.3	211.99
Other Current Assets	556.9	252.18	398.75	433.12	48.13	28.95
Total Current Assets	2,293	1,857	2,151	2,399	2,365	2,117
Property, Plant & Equipment	745.41	707.48	703.86	556.49	452.2	369.63
Long-Term Investments	238.89	889.75	641.21	223.6	142.86	75.69
Goodwill	12.02	0.31	26.14	26.14	26.14	26.14
Other Intangible Assets	146.3	141.55	113.79	103.91	77.21	63.59
Long-Term Accounts Receivable	2.43	4.9	8.23	9.25	10.93	-
Long-Term Deferred Tax Assets	53.96	47.89	43.18	35.48	14.92	10.42
Long-Term Deferred Charges	59.18	55.07	80.12	51.05	43.68	34.48
Other Long-Term Assets	285.16	3.39	3.92	273.63	4.56	3.21
Total Assets	3,837	3,707	3,772	3,679	3,138	2,700
Accounts Payable	191.6	77.4	73.73	102.95	110.97	95.91
Accrued Expenses	57.21	98.39	103.03	120.22	85	81.26
Short-Term Debt	625.76	575.57	641.29	551.94	464.37	364.79
Current Portion of Long-Term Debt	-	-	12.89	25.8	0.2	-
Current Portion of Leases	3.65	4.38	9.79	5.63	2.1	-
Current Income Taxes Payable	21.01	12.2	9.58	9.04	10.48	17.6
Current Unearned Revenue	39.67	34.87	38.17	75.37	94.29	36.05
Other Current Liabilities	48.75	137.22	90.91	67.12	46.08	61
Total Current Liabilities	987.66	940.01	979.38	958.06	813.48	656.61
Long-Term Debt	-	-	-	3	27.78	20
Long-Term Leases	1.63	1.62	2.71	4.65	2	-
Long-Term Unearned Revenue	16.44	18.3	20.88	23.47	5.87	7.81
Long-Term Deferred Tax Liabilities	29.46	26.48	27.41	24.2	13.96	10.94
Other Long-Term Liabilities	-	-	-	0.91	0.8	0.6
Total Liabilities	1,035	986.42	1,030	1,014	863.9	695.95
Common Stock	507.15	507.15	507.15	507.15	363.81	260.34
Additional Paid-In Capital	236.14	236.18	314.01	318.24	511.58	612.36
Retained Earnings	1,935	1,865	1,732	1,655	1,280	973.8
Treasury Stock	-	-	-	-	-50	-8.75
Comprehensive Income & Other	13.03	10.16	5.87	1.69	1.37	0.23
Total Common Equity	2,691	2,619	2,559	2,482	2,106	1,838
Minority Interest	110.28	101.99	181.92	182.13	167.63	166.05
Shareholders' Equity	2,801	2,721	2,741	2,665	2,274	2,004
Total Liabilities & Equity	3,837	3,707	3,772	3,679	3,138	2,700
Total Debt	631.03	581.57	666.68	591.02	496.44	384.79
Net Cash (Debt)	509.04	418.9	269.56	566.37	1,085	1,012
Net Cash Growth	11.17%	55.40%	-52.41%	-47.81%	7.27%	-2.90%
Net Cash Per Share	1.00	0.82	0.53	1.11	2.12	1.99
Filing Date Shares Outstanding	507.15	507.15	507.15	507.15	507.15	507.21
Total Common Shares Outstanding	507.15	507.15	507.15	507.15	507.15	510.27
Working Capital	1,306	917.03	1,172	1,441	1,552	1,460
Book Value Per Share	5.31	5.16	5.05	4.89	4.15	3.60
Tangible Book Value	2,533	2,477	2,419	2,352	2,003	1,748
Tangible Book Value Per Share	4.99	4.88	4.77	4.64	3.95	3.43
Buildings	-	273.29	247.34	243.57	240.18	229.04
Machinery	-	527.67	529.3	440.02	296.94	240.51
Construction In Progress	-	225.08	205.76	86.37	80.86	35.59

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.